New Directions in Health: The Global Burden of Chronic Disease
8 December 2005
Cardiovascular disease, cancer, diabetes,
and obesity now account for almost half the global burden of disease.
These chronic diseases are no longer a developed country problem.
More people die from so-called "rich country diseases" in
low- and middle-income countries than in the developed world. This
seminar draws together a select group of individuals to examine the
newest understandings and technologies for treating and managing chronic
disease. As new directions in technology and treatment are uncovered
and strategies reassessed, the goal of relieving the global burden
of these diseases becomes ever more reachable.
MODERATOR
Alan I. Leshner,
Chief Executive Officer, AAAS, and
Executive Publisher of the journal, Science
KEYNOTE LECTURES
The
Global Picture
Robert
Beaglehole, Director of Chronic Diseases and Health Promotion,
World Health Organization
The Promise of Biomaterials and Tissue Engineering [video
not available]
Robert S. Langer, Institute
Professor, Department of Chemical Engineering, Massachusetts Institute
of Technology
PREDICTION AND DIAGNOSIS IN MODERN MEDICINE
Cardiovascular Disease
A
Targeted Approach to Heart Attack and Coronary Disease
Eric
J. Topol, Provost, Cleveland Clinic Lerner College of Medicine;
Chair, Department of Cardiovascular Medicine; and Professor of Medicine
and Genetics, Case Western Reserve University
Diabetes
Developing
Noninvasive Methods To Measure Susceptibility
Gerald
I. Shulman, Professor of Internal Medicine and Cellular and Molecular
Physiology, Yale University; Investigator, Howard Hughes Medical Institute
Cancer
Personalized
Medicine Versus Personalized Disease?
Michael Liebman, Executive
Director, Windber Research Institute
PREVENTION AND TREATMENT
Cancer Treatment
Vascular
Endothelial Growth Factor: From Bench to Bedside
Napoleone
Ferrara, Researcher, Molecular Oncology, Genentech
Obesity
Obesity
and the Environment: An Update
Holly
Wyatt, Assistant Professor of Medicine, Division of Endocrinology,
Metabolism, and Diabetes, Center for Human Nutrition; Program Director,
Centers for Obesity Research and Education, University of Colorado
Health Sciences Center
High Blood Pressure
Metabolic
Pathways that Govern Hypertension and Potential Treatment Targets
Rick
Lifton, Sterling Professor and Chairman, Department of Genetics;
Professor of Medicine and Molecular Biophysics and Biochemistry; Howard
Hughes Medical Institute; Yale University School of Medicine
Medical Devices
Technological
Strategies [video not available]
Robert
T.V. Kung, Senior Vice President and Chief Scientific Officer,
ABIOMED
Artificial and Transplanted Organs
Growing
Artificial Hearts
Michael
Sefton, Professor of Biomedical Engineering, University of Toronto
ETHICAL AND SOCIAL ISSUES
Closing
Lecture: Is Global Chronic Disease Bankable? The Need for a New Approach
with New Actors, New Motivations, and New Horizons
Susan
Raymond, Senior Managing Director for Research, Evaluation, and
Strategic Planning, Changing Our World, Inc.
The Abelson Advancing Science Seminar Series Advisory Committee
AAAS thanks the Abelson Advancing Science Seminar Series Advisory
Committee whose support was critical in developing the 2005 program.
Members included colleagues and family members of Dr. Abelson who
helped preserve his vision.
John Abelson
Ellen Abelson Cherniavsky
Mr. and Mrs. John P. Cherniavsky
Neva Cherniavsky
Stephen P.A. Fodor
Claire Fraser
Maxine Frank Singer
|
